Abstract
Mutations in APC are classically associated with familial adenomatous polyposis (FAP), a highly penetrant autosomal dominant disorder characterized by multiple intestinal polyps and, without surgical intervention, the development of colorectal cancer1 (CRC). APC is a tumour-suppressor gene, and somatic loss occurs in tumours. The germline T-to-A transversion responsible for the APC I1307K allele converts the wild-type sequence to a homopolymer tract (A8) that is genetically unstable and prone to somatic mutation. The I1307K allele was found in 6.1% of unselected Ashkenazi Jews and higher proportions of Ashkenazim with family or personal histories of CRC (ref. 2). To evaluate the role of I1307K in cancer, we genotyped 5,081 Ashkenazi volunteers in a community survey. Risk of developing colorectal, breast and other cancers were compared between genotyped I1307K carriers and non-carriers and their first-degree relatives.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Petersen, G.M. Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann. Med. 26, 205–208 (1994).
Laken, S.J. et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet. 17, 79– 83 (1997).
Struewing, J.P. et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336 , 1401–1408 (1997).
Wacholder, S. et al. The kin-cohort study for estimating penetrance. Amer. J. Epidemiology, in press (1998).
Feuer, E.J. et al. The lifetime risk of developing breast cancer. J. Natl Cancer Inst. 85, 892–897 (1993).
Feuer, E.J. & Wun, L.M. DEVCAN: Probability of DEVeloping CANcer Software National Cancer Institute, Bethesda ( 1997).
Petrukhin, L. et al. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds. Cancer Res. 57, 5480–5484 (1997).
Thompson, A.M. et al. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br. J. Cancer 68, 64–68 (1993).
Kashiwaba, M., Tamura, G. & Ishida, M. Aberrations of the APC gene in primary breast carcinoma. J. Cancer Res. Clin. Oncol. 120, 727– 731 (1994).
Medeiros, A.C., Nagai, M.A., Neto, M.M. & Brentani, R.R. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas. Cancer Epidemiol. Biomarkers Prev. 3, 331 –333 (1994).
Nugent, K.P., Spigelman, A.D. & Phillips, R.K. Risk of extracolonic cancer in familial adenomatous polyposis. Br. J. Surg. 83, 1121– 1122 (1996).
Moser, A.R. et al. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl Acad. Sci. USA 90, 8977– 8981 (1993).
Redston, M. et al. The APC I1307K polymorphism and breast cancer risk. Nature Genet. 20, 13–14 (1998).
Giardiello, F.M. et al. Risk of hepatoblastoma in familial adenomatous polyposis. J. Pediatr. 119, 766–768 (1991).
Hamilton, S.R. et al. The molecular basis of Turcot's syndrome. N. Engl. J. Med. 332, 839–847 ( 1995).
Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759– 767 (1990).
Morin, P.J. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787–1790 (1997).
Rubinfeld, B. et al. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790– 1792 (1997).
Caporaso, N., DeBaun, M.R. & Rothman, N. Lung cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association. Pharmacogenetics 5, S129–134 ( 1995).
Perera, F.P. Environment and cancer: who are susceptible? Science 278, 1068–1073 (1997).
Acknowledgements
We are grateful to B. Vogelstein, K. Kinzler and M. Redston for communication of unpublished results. F. Collins, M. Gail, R. Hoover, K. Offit, W. Foulkes, B. Vogelstein and G. Petersen all made helpful suggestions regarding the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woodage, T., King, S., Wacholder, S. et al. The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 20, 62–65 (1998). https://doi.org/10.1038/1722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/1722
This article is cited by
-
Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants
Breast Cancer Research and Treatment (2020)
-
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms
Breast Cancer Research and Treatment (2019)
-
Outcomes of retesting BRCA negative patients using multigene panels
Familial Cancer (2017)
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
European Journal of Human Genetics (2016)
-
Engaging diverse communities participating in clinical trials: case examples from across Africa
Malaria Journal (2010)